Correction: Horizon Pharma IPO filingBy AP
Thursday, August 5, 2010
Correction: Horizon Pharma IPO filing
NEW YORK — In a story Aug. 4 about Horizon Pharma Inc., The Associated Press reported erroneously on the company’s partnerships on its drug Lodotra. Mundipharma holds the rights to Lodotra in Europe except for Germany and Austria, and Merck Serono has the rights to Lodotra in Germany and Austria.